Lenoss Medical, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Lenoss Medical, Inc. - overview

Established

2016

Location

Providence, RI, US

Primary Industry

Medical Devices & Equipment

About

Based in Rhode Island, US, founded in 2016, and is led by President and Chief Executive Officer Dom Messerli, Lenoss Medical, LLC operates as a developer of medical devices and equipment with biologic cementless technology for stabilizing damaged vertebrae. In March 2026, Lenoss Medical, Inc. raised USD 6 million in venture funding from Xcellerant Ventures, RightHill Ventures, Highpoint Ventures, Beacon Angels, Magpie MedTech Ventures, and Arizona Venture Development Corporation.   Lenoss Medical, LLC developed the OsteoPearl VBA System, which is a spinal implant technology for stabilizing fractures but also provides a clinically support.


The company offers medical solutions for improving bone mass and strengthening bones. In addition, the firm provides support and treatment for a variety of diseases such as severe back pain, immobility, deformity, increased health complications, decreased life expectancy, loss of self-esteem, distorted body image, and depression.   The company plans to utilize the March 2026 funding to expand commercially, hire sales leaders, boost clinical data efforts, and grow operations and marketing.


Current Investors

Xcellerant Ventures, Vodia Ventures, Highpoint Ventures

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Devices & Equipment

Website

www.lenoss.com

Verticals

Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.